Trigeminal Neuralgia — Medication & Microvascular Decompression in Noida

Microvascular decompression (MVD) surgery has the highest long-term pain relief rate — approximately 80% of patients are pain-free at 1 year and 70% at 10 years. It treats the underlying cause (nerve compression by a blood vessel) rather than the nerve itself. MVD requires a posterior fossa craniotomy; it is appropriate for younger, fit patients. Dr. Manish Vaish (AANS International Fellow) performs MVD at Medanta Hospital, Noida.

Yes. Carbamazepine is the first-line evidence-based medication for trigeminal neuralgia and provides complete or near-complete relief in 60–80% of patients. Blood levels and blood count monitoring are needed. If carbamazepine is not tolerated or becomes ineffective, the next step is oxcarbazepine or alternative medications. Failure of or intolerance to medications is the indication for procedures or surgery.

In a minority of cases (approximately 2–4%), trigeminal neuralgia is caused by multiple sclerosis — a demyelinating plaque at the trigeminal root entry zone. MS-related TN is more common in younger patients and may be bilateral. MRI brain and spine is performed for TN patients under 50 to exclude demyelinating disease. Dr. Kapil Singhal and Dr Namita Kaul at Team Sushrut evaluates MS-related TN.

Dr. Manish Vaish (AANS International Fellow) and Team at Medanta Hospital, Sector 50, Noida performs microvascular decompression (MVD) for trigeminal neuralgia. MVD is also called Jannetta procedure and is the surgery with the highest durable pain relief rate for classical TN. Contact Team Sushrut at +91 98103 24401.